ArticleCase reports in oncological medicine2025

Adding Docetaxel to Tepotinib to Overcome Oligoprogression in MET Exon 14 Skipping-Mutated NSCLC When Local Therapy Is Unfeasible: A Case Report.

David Sánchez García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.